trial · primary record
CAR T cells
Multiple Myeloma
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 20 |
| Primary completion | 2030-12-31 |
| Primary endpoint | Percentage of patients with treatment related adverse effect |
| Registry ID | NCT03271632 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:44:50.430Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03271632
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.